Changes in motor cortex excitability in facioscapulohumeral muscular dystrophy.
Previous studies found that some patients with severe, early onset facioscapulohumeral muscular dystrophy (FSHD) present epilepsy and mental retardation. This suggests a functional involvement of central nervous system in severe FSHD. It is unknown whether minor functional changes of central nervous system are also present in less severe forms of FSHD. To investigate this, we examined the excitability of neuronal networks of the motor cortex with a range of transcranial magnetic stimulation paradigms in 20 FSHD patients with heterogeneous clinical severity and compared the data with that from 20 age-matched healthy individuals and from 6 age-matched patients with other muscle diseases. There was significantly less intracortical inhibition in FSHD patients (mean responses +/- SD reduced to 58.1+/-43.5% of the test size) than in controls (mean responses +/- SD reduced to 29.3+/-13.5% of the test size; P=0.025) and in patients with other muscle diseases (mean responses +/-SD, reduced to 30.6+/-11.7% of the test size; P=0.046). No significant difference was found between the control group and patients with other muscle diseases (P=0.970).
Di Lazzaro
V
V
Institute of Neurology, Università Cattolica, Largo A. Gemelli 8, Rome 00168, Italy. vdilazzaro@rm.unicatt.it
Oliviero
A
A
Tonali
P A
PA
Felicetti
L
L
De Marco
M B P
MB
Saturno
E
E
Pilato
F
F
Pescatori
M
M
Dileone
M
M
Pasqualetti
P
P
Ricci
E
E
D000293:Adolescent; D000328:Adult; D026261:Diazepam Binding Inhibitor / Q000378:metabolism; D004558:Electric Stimulation; D004827:Epilepsy / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D008607:Intellectual Disability / Q000175:diagnosis / Q000209:etiology; D007360:Intelligence / Q000235:genetics; D008280:Magnetics; D008875:Middle Aged; D008969:Molecular Sequence Data; D009044:Motor Cortex / Q000503:physiopathology*; D018482:Muscle, Skeletal / Q000378:metabolism / Q000503:physiopathology; D020391:Muscular Dystrophy, Facioscapulohumeral / Q000150:complications* / Q000503:physiopathology*; D009431:Neural Conduction / Q000235:genetics; D009433:Neural Inhibition / Q000235:genetics; D009434:Neural Pathways / Q000503:physiopathology*; D011712:Pyramidal Tracts / Q000503:physiopathology; D011930:Reaction Time / Q000235:genetics; D011963:Receptors, GABA-A / Q000235:genetics / Q000378:metabolism; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D026261:Diazepam Binding Inhibitor; D011963:Receptors, GABA-A; D005680:gamma-Aminobutyric Acid